A Multicenter, Double-Blind, Placebo-Controlled, Randomized, 2-Arm Phase IIa Pilot Trial Assessing the Effect of Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria

Trial Profile

A Multicenter, Double-Blind, Placebo-Controlled, Randomized, 2-Arm Phase IIa Pilot Trial Assessing the Effect of Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Sapropterin (Primary)
  • Indications Phenylketonuria
  • Focus Adverse reactions
  • Acronyms SIGNAL
  • Sponsors Merck KGaA
  • Most Recent Events

    • 13 May 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 21 Nov 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
    • 18 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top